Marcella Visentini

Pubblicazioni

Titolo Pubblicato in Anno
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study BIOMEDICINES 2023
Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients THROMBOSIS AND HAEMOSTASIS 2023
Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2 JOURNAL OF THROMBOSIS AND HAEMOSTASIS 2023
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity JOURNAL OF CLINICAL IMMUNOLOGY 2023
Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia FRONTIERS IN IMMUNOLOGY 2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy ANNALS OF HEMATOLOGY 2023
Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyper-activation and associate with high platelet-lymphocyte and low platelet-neutrophil aggregates RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS 2023
Persistence of monoclonal B-cell expansion and intraclonal diversification despite virus eradication in patients affected by hepatitis C virus-associated lymphoproliferative disorders BRITISH JOURNAL OF HAEMATOLOGY 2023
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2023
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) CLINICAL RHEUMATOLOGY 2023
Correction to: management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) CLINICAL RHEUMATOLOGY 2023
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase JOURNAL OF TRANSLATIONAL AUTOIMMUNITY 2023
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group RMD OPEN 2023
Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature FRONTIERS IN ONCOLOGY 2023
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2 EARD 2022
Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA covid-19 vaccine JOURNAL OF THROMBOSIS AND HAEMOSTASIS 2022
Relapse of HCV-Cryoglobulinemic Vasculitis Following Sustained Viral Response after Interferon-free Direct-Acting Antivirals THE AMERICAN JOURNAL OF GASTROENTEROLOGY 2022
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases CLINICAL RHEUMATOLOGY 2022
Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature AUTOIMMUNITY REVIEWS 2022
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases ANNALS OF THE RHEUMATIC DISEASES 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma